Maternally derived antibodies against bordetella pertussis antigens pertussis toxin and filamentous hemagglutinin in preterm and full term newborns

Pediatric Infectious Disease Journal

Volumn 28, Issue 5, 2009, Pages 443-445

  Heininger, Ulrich ^a   Riffelmann, Marion ^b,c   Leineweber, Birgit ^a   Wirsing Von Koenig, Carl Heinz ^b,c  

^a UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^b Institut fuer Infektiologie Krefeld   (Germany)

^c HELIOS KLINIKUM KREFELD   (Germany)

Author keywords

Antibodies; Bordetella pertussis; ELISA; Immunity; Infant; Maternally acquired; Premature

Indexed keywords

BORDETELLA PERTUSSIS ANTIGEN; DIPHTHERIA PERTUSSIS TETANUS VACCINE; HEMAGGLUTININ; IMMUNOGLOBULIN G ANTIBODY; MATERNAL ANTIBODY; PERTUSSIS TOXIN; UNCLASSIFIED DRUG;

ADULT; ANTIBODY DETECTION; ANTIBODY RESPONSE; ARTICLE; BORDETELLA PERTUSSIS; DISEASE PREDISPOSITION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MATHEMATICAL ANALYSIS; NEWBORN; NEWBORN CARE; PERTUSSIS; PLACENTAL TRANSFER; PREMATURITY; PRIORITY JOURNAL; SERODIAGNOSIS;

EID: 67649515883     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e318193ead7     Document Type: Article

References (16)

1. Heininger U. Pertussis: an old disease that is still with us. Curr Opin Infect Dis. 2001;14:329-335.
2. Cortese MM, Baughman AL, Zhang R, et al. Pertussis hospitalizations among infants in the United States, 1993 to 2004. Pediatrics. 2008;121: 484-492.
3. Malek A, Sager R, Kuhn P, et al. Evolution of maternofetal transport of immunoglobulins during human pregnancy. Am J Reprod Immunol. 1996; 36:248-255.
4. Belloni C, De Silvestri A, Tinelli C, et al. Immunogenicity of a three-component acellular pertussis vaccine administered at birth. Pediatrics. 2003;111:1042-1045.
5. Gonik B, Puder KS, Gonik N, et al. Seroprevalence of Bordetella pertussis antibodies in mothers and their newborn infants. Infect Dis Obstet Gynecol. 2005;13:59-61.
6. Healy MC, Munoz FM, Rench MA, et al. Prevalence of pertussis antibodies in maternal delivery, cord, and infant serum. J Infect Dis. 2004;190:335-340.
7. van Savage J, Decker M, Edwards K, et al. Natural history of pertussis antibody in the infant and effect on vaccine response. J Infect Dis. 1990;161:487-492.
8. Leineweber B, Grote V, Schaad UB, et al. Transplacentally acquired immunoglobulin G antibodies against measles, mumps, rubella and varicella-zoster virus in preterm and full term newborns. Pediatr Infect Dis J. 2004;23:361-363.
9. Wirsing von König CH, Gounis D, Laukamp S, et al. Evaluation of a single-sample serological technique for diagnosing pertussis in unvaccinated children. Eur J Clin Microbiol Infect Dis. 1999;18:341-345.
10. Cattaneo LA, Reed GW, Haase DH, et al. The seroepidemiology of Bordetella pertussis infections: a study of persons ages 1 to 65 years. J Infect Dis. 1996;173:1256-1259.
11. Nomura M, Kuno-Sakai H, Kimura M, et al. Dynamics of transplacental transmission of pertussis antibodies in premature and full-term infants. Tokai J Exp Clin Med. 2003;28:21-26.
12. Heininger U, Cherry JD, Christenson P, et al. Comparative study of Lederle/Takeda acellular and whole-cell pertussis component diphtheriatetanus- pertussis vaccines in infants in Germany. Vaccine. 1994;12:81- 86.
13. Englund JA, Anderson EL, Reed GF, et al. The effect of maternal antibody on the serologic response and the incidence of adverse reactions after primary immunization with acellular and whole-cell pertussis vaccines combined with diphtheria and tetanus toxoids. Pediatrics. 1995;96:580 -584.
14. Knuf M, Schmitt HJ, Wolter J, et al. Neonatal vaccination with an acellular pertussis vaccine accelerates the acquisition of pertussis antibodies in infants. J Pediatr. 2008;152:655- 660.
15. Kendrick P, Thompson M, Elderling G. Immunity responses of mothers and babies to injections of pertussis vaccine during pregnancy. Am J Dis Child. 1945;70:25-28.
16. Mooi FR, de Greeff SC. The case for maternal vaccination against pertussis. Lancet Infect Dis. 2007;7:614-624.